8-K - Cognition Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On December 18, 2025, Cognition Therapeutics, Inc. (the “ Company”) entered into an Open Market Sale Agreement SM (t

Material Agreement

$75.0M

1.02

Termination of a Material Definitive Agreement. As previously disclosed, on December 23, 2022, the Company entered into a Controlled Equity Offering SM Sales Ag

Material Agreement

$40.0M$12.5M

Exhibits (1)

8-K

FORM 8-K